UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2015-08, Vol.61 (3), p.403-408

2015

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

AIDS (London), 2010-11, Vol.24 (18), p.2827-2833

2010

Link zum Volltext

Verfügbarkeit prüfen

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Clinical infectious diseases, 2010-05, Vol.50 (9), p.1300-1308

2010

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

AIDS (London), 2012-11, Vol.26 (18), p.2285-2293

2012

Link zum Volltext

Verfügbarkeit prüfen

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses

The Journal of immunology (1950), 2020-12, Vol.205 (12), p.3348-3357

2020

Link zum Volltext

Verfügbarkeit prüfen

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

Telemedicine journal and e-health, 2021-04, Vol.27 (4), p.432

2021

Link zum Volltext

Verfügbarkeit prüfen

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

Clinical infectious diseases, 2005-09, Vol.41 (6), p.901-905

2005

Link zum Volltext

Verfügbarkeit prüfen

Memory B cell dysregulation in HIV-1-infected individuals

AIDS (London), 2018-01, Vol.32 (2), p.149-160

2018

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

AIDS (London), 2016-09, Vol.30 (15), p.2275-2287

2016

Link zum Volltext

Verfügbarkeit prüfen

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

Annals of internal medicine, 2003-07, Vol.139 (2), p.81

2003

Link zum Volltext

Verfügbarkeit prüfen

TL1A-DR3 plasma levels are predictive of HIV-1 disease control, and DR3 co-stimulation boosts HIV-1-specific T-cell responses

The Journal of immunology (1950), 2020-11, Vol.205 (12), p.3348-3357

2020

Link zum Volltext

Verfügbarkeit prüfen

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

AIDS (London), 2011-06, Vol.25 (10), p.1271-1280

2011

Link zum Volltext

Verfügbarkeit prüfen

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Clinical infectious diseases, 2002-02, Vol.34 (4), p.504-510

2002

Link zum Volltext

Verfügbarkeit prüfen

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

AIDS (London), 2000-03, Vol.14 (4), p.397-403

2000

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic management of bone demineralization in the HIV-infected population

AIDS (London), 2007-03, Vol.21 (6), p.657-663

2007

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review

AIDS reviews, 2009-04, Vol.11 (2), p.103-109

2009

Link zum Volltext

Verfügbarkeit prüfen

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients

AIDS (London), 2018-07, Vol.32 (11), p.1431-1442

2018

Link zum Volltext

Verfügbarkeit prüfen

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

AIDS (London), 2019-07, Vol.33 (9), p.1455-1465

2019

Link zum Volltext

Verfügbarkeit prüfen

HIV protease inhibitors and dyslipidemia

AIDS reviews, 2003-01, Vol.5 (1), p.19

2003

Link zum Volltext

Verfügbarkeit prüfen

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

AIDS (London), 2010-04, Vol.24 (7), p.959-968

2010

Link zum Volltext

Verfügbarkeit prüfen

HIV and aging, biological mechanisms, and therapies: What do we know?

AIDS reviews, 2022-04, Vol.24 (2), p.79-86

2022

Link zum Volltext

Verfügbarkeit prüfen

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

AIDS (London), 2006-02, Vol.20 (4), p.619-621

2006

Link zum Volltext

Verfügbarkeit prüfen

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia

AIDS (London), 2018-06, Vol.32 (10), p.1309-1316

2018

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

International journal of STD & AIDS, 2020-04, Vol.31 (5), p.467-473

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Immunology
(33)
Humans
(32)
Infectious Diseases
(32)
Hiv Infections - Drug Therapy
(25)
Virology
(23)
Aids/hiv
(22)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Male
(18)
Antiviral Agents
(17)
Female
(17)
Pharmacology. Drug Treatments
(17)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(16)
Human Viral Diseases
(16)
Viral Diseases
(16)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(16)
Adult
(15)
Human Immunodeficiency Virus
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

Memory B cell dysregulation in HIV-1-infected individuals

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

TL1A-DR3 plasma levels are predictive of HIV-1 disease control, and DR3 co-stimulation boosts HIV-1-specific T-cell responses

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

Therapeutic management of bone demineralization in the HIV-infected population

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

HIV protease inhibitors and dyslipidemia

Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

HIV and aging, biological mechanisms, and therapies: What do we know?

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

Aktive Filter

Suchergebnisse filtern